DR. WILLIAM JOSEPH BARRISH M.D.
Prescription History 1396796413
Physical Medicine & Rehabilitation in Lewes, DE


Quality Rating: 0 out of 100 score

NPI Status: Active since May 13, 2006

Contact Information

17637 SHADY RD UNIT 102
LEWES, DE
ZIP 19958
Phone: (302) 430-3205
Fax: (877) 415-1716

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. WILLIAM JOSEPH BARRISH M.D., an active Physical Medicine & Rehabilitation specialist practicing in Lewes, DE. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 130 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 40 claims alone.

Medication Index

No matching medications currently found on file.

Baclofen

Generic Formulation: BaclofenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 19
30-Day Fills 29.0
Days Supply 850
DE State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills43.0
Peer Average Days Supply1,211
Conservative Utilization

This provider writes prescriptions for this formulation 40.6% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $869.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$45.77

State Avg Cost Per Claim

$37.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Botox

Generic Formulation: OnabotulinumtoxinaSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 35
30-Day Fills 90.4
Days Supply 2,713
DE State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills69.2
Peer Average Days Supply2,061
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 29.6% more claims than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $62,053.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,772.96

State Avg Cost Per Claim

$1,404.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.

Therapeutic Applications

There are different types of botulinum toxin products (toxin A and B) with different uses (eye problems, muscle stiffness/spasms, migraines, cosmetic, overactive bladder). Different brands of this medication deliver different amounts of medication. Your doctor will choose the correct product for you. Botulinum toxin is used to treat certain eye disorders such as crossed eyes (strabismus) and uncontrolled blinking (blepharospasm), to treat muscle stiffness/spasms or movement disorders (such as cervical dystonia, torticollis), and to reduce the cosmetic appearance of wrinkles. It is also used to prevent headaches in people with very frequent migraines. Botulinum toxin relaxes muscle by blocking the release of a chemical called acetylcholine. Botulinum toxin is also used to treat overactive bladder by patients who do not respond to or who cannot tolerate the side effects of other medications. It helps to reduce leaking of urine, feeling of needing to urinate right away, and frequent trips to the bathroom. It is also used to treat severe underarm sweating and drooling/excess saliva. Botulinum toxin works by blocking the chemicals that turn on the sweat and salivary glands. Botulinum toxin is not a cure, and your symptoms will gradually return as the medication wears off.

Cyclobenzaprine Hcl

Generic Formulation: Cyclobenzaprine HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 288
DE State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills37.1
Peer Average Days Supply932
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.8% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $56.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.06

State Avg Cost Per Claim

$16.52

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Gabapentin

Generic Formulation: GabapentinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 40
30-Day Fills 111.3
Days Supply 3,340
DE State Average Benchmarks
Peer Average Claims79.0
Peer Average 30-Day Fills130.2
Peer Average Days Supply3,818
Conservative Utilization

This provider writes prescriptions for this formulation 49.4% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,405.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.13

State Avg Cost Per Claim

$21.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 22
30-Day Fills 50.0
Days Supply 1,500
DE State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills75.9
Peer Average Days Supply2,232
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $184.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.38

State Avg Cost Per Claim

$6.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. WILLIAM JOSEPH BARRISH M.D. provides transparency into local medical care patterns within Lewes, DE.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Physical Medicine & Rehabilitation** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.